Vivus Receives $140 Million Milestone Payment From KV Pharma

Vivus, Inc. has received a $140 million milestone payment from KV Pharmaceutical (KV) pursuant to the previously announced transfer of exclusive rights and assets related to Evamist.
Pharmabiz